BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25063264)

  • 21. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
    Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
    BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of quality measure attainment with pharmacist-delivered Medicare annual wellness visits.
    Osae SP; Young HN; Fricks WP; Zillich AJ
    J Am Pharm Assoc (2003); 2022; 62(2):559-563. PubMed ID: 34799260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a pharmacist in improving quality measures that affect payments to physicians.
    Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S85-S90. PubMed ID: 31203017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Pharmacist Involvement in Medicare Wellness Visits.
    Tran T; Miller H; Ivy D
    J Pharm Pract; 2020 Dec; 33(6):745-748. PubMed ID: 30808266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of quality measures performed through pharmacist collaboration with a primary care clinic.
    Yon K; Sinclair J; Bentley OS; Abubakar A; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2020; 60(3S):S97-S102. PubMed ID: 32536482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Financial performance and reimbursement of pharmacist-led chronic care management.
    Martin R; Tram K; Le L; Simmons C
    Am J Health Syst Pharm; 2020 Nov; 77(23):1973-1979. PubMed ID: 32995845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicare Chronic Care Management Payments and Financial Returns to Primary Care Practices: A Modeling Study.
    Basu S; Phillips RS; Bitton A; Song Z; Landon BE
    Ann Intern Med; 2015 Oct; 163(8):580-8. PubMed ID: 26389533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic.
    Lobas NH; Lepinski PW; Abramowitz PW
    Am J Hosp Pharm; 1992 Jul; 49(7):1681-8. PubMed ID: 1621723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of annual wellness visits provided by pharmacists in an accountable care organization associated with a federally qualified health center.
    Alhossan A; Kennedy A; Leal S
    Am J Health Syst Pharm; 2016 Feb; 73(4):225-8. PubMed ID: 26843499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic.
    Clark CM; LaValley SA; Singh R; Mustafa E; Monte SV; Wahler RG
    J Am Pharm Assoc (2003); 2020; 60(1):105-111. PubMed ID: 31690514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Interventions in Clinical Pharmacist-Led Annual Medicare Wellness Visits Compared with Usual Care.
    Beliard RC; Merrey JW
    Consult Pharm; 2017 Nov; 32(11):687-699. PubMed ID: 29113636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic terminology in obtaining reimbursement for pharmacists' cognitive services.
    Nutescu EA; Klotz RS
    Am J Health Syst Pharm; 2007 Jan; 64(2):186-92. PubMed ID: 17215470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing unnecessary hospital readmissions: the pharmacist's role in care transitions.
    Novak CJ; Hastanan S; Moradi M; Terry DF
    Consult Pharm; 2012 Mar; 27(3):174-9. PubMed ID: 22421517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Access to clinical pharmacy services in a pharmacist-physician covisit model.
    Ulrich IP; Lugo B; Hughes P; Doucette L; Creith BB; Flanagan S; Gilmer B
    Res Social Adm Pharm; 2021 Jul; 17(7):1321-1326. PubMed ID: 33153913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicare Annual Wellness Visits: patient need and pharmacist patient care services intersect.
    Heaton PC
    J Am Pharm Assoc (2003); 2014; 54(4):336-7. PubMed ID: 25063255
    [No Abstract]   [Full Text] [Related]  

  • 38. Team-based approach to addressing simvastatin safety concerns.
    Robinson M; Gunning K; Pippitt K; McAdam-Marx C; Jennings BT
    J Am Pharm Assoc (2003); 2013; 53(5):539-44. PubMed ID: 24030132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and implementation of ambulatory care pharmacy services at an internal medicine clinic.
    Wells C; Warren AC; Ashe Scott M
    Am J Health Syst Pharm; 2024 Apr; ():. PubMed ID: 38613410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Providing pharmaceutical care in a physician office.
    Campbell RK; Saulie BA
    J Am Pharm Assoc (Wash); 1998; 38(4):495-9. PubMed ID: 9707960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.